Macrogenics (MGNX) Capital Expenditures (2012 - 2026)
Macrogenics' (MGNX) quarterly Capital Expenditures came in at $276000.0 in Q1 2026, down 21.81% year-on-year from $353000.0 in Q1 2025, and up 487.23% on a QoQ basis from $47000.0 in Q4 2025.
Macrogenics (MGNX) Capital Expenditures (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Capital Expenditures data on file, last reported at $276000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 21.81% year-over-year to $276000.0 in Q1 2026; TTM through Mar 2026 was -$23000.0, a 100.6% decrease from a year earlier, with the FY2025 full-year figure at $54000.0, down 98.54% from the prior year.
- Capital Expenditures for Q1 2026 stood at $276000.0, up from $47000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for MGNX reached as high as $3.0 million in Q3 2024 and fell as low as -$639000.0 in Q4 2023.
- Historically, Capital Expenditures has averaged $480235.3 across 5 years, with a median of $353000.0 in 2025.
- Across the five-year window, Capital Expenditures tumbled 262.6% in 2023 and soared 511.22% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at $393000.0 in 2022, then tumbled by 262.6% to -$639000.0 in 2023, then jumped by 197.03% to $620000.0 in 2024, then tumbled by 92.42% to $47000.0 in 2025, then surged by 487.23% to $276000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $276000.0 in Q1 2026, $47000.0 in Q4 2025, and -$26000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | 276,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 276,000.00 |
| Mar 31, 2026 | 276,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Sep 30, 2025 | -26,000.00 |
| Sep 30, 2025 | -26,000.00 |
| Jun 30, 2025 | -320,000.00 |
| Jun 30, 2025 | -320,000.00 |
| Mar 31, 2025 | 353,000.00 |
| Mar 31, 2025 | 353,000.00 |
| Dec 31, 2024 | 620,000.00 |
| Dec 31, 2024 | 620,000.00 |
| Sep 30, 2024 | 3.05 Mn |
| Sep 30, 2024 | 3.05 Mn |
| Jun 30, 2024 | -206,000.00 |
| Jun 30, 2024 | -206,000.00 |
| Mar 31, 2024 | 242,000.00 |
| Mar 31, 2024 | 242,000.00 |
| Dec 31, 2023 | -639,000.00 |
| Dec 31, 2023 | -639,000.00 |